5-AMP-Activated Protein Kinase, Gamma-2 Subunit (PRKAG2) Mutation Analysis
Apolipoprotein L1 (APOL1) Genotyping for Chronic Kidney Diseases
Glomerular Filtration Rate, Estimated (eGFR)
Salmonella infections and gastroenteritis
Sickle cell anemia
Ehrlichiosis
NRAS (Neuroblastoma RAS Viral Oncogene Homolog) Gene Mutation Analysis
Androgen Receptor (AR) Gene Mutation Analysis
Brucella Antibody, IgG and IgM
Acyclovir, Serum
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Specimen Collection
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now